Currently, there is tremendous enthusiasm regarding the development of immunotherapies to fight cancer. Researchers in this area are discovering novel ways to harness small molecules and biologics to trigger the patient’s own immune system to fight cancer tumors, which has the potential to affect the lives of many patients with cancer today, as well as future generations.
Regulatory agencies, including the U.S. Food and Drug Administration and European Medicines Agency, are showing significant interest in the potential of immunotherapy, which is spurring investment in this area. However, there are still many challenges to bringing these therapies to market. - See more at: http://www.quintiles.com/blog/immunotherapy-development-the-top-10-obstacles-to-market-success#sthash.qtGfSJYg.dpuf
Immunotherapy development: The top 10 obstacles to market success - Quintiles
No comments:
Post a Comment